Literature DB >> 19439362

Cost-effectiveness of a minimal intervention for stress-related sick leave in general practice: results of an economic evaluation alongside a pragmatic randomised control trial.

Kimi Uegaki1, Ingrid Bakker, Martine de Bruijne, Allard van der Beek, Berend Terluin, Harm van Marwijk, Martijn Heymans, Wim Stalman, Willem van Mechelen.   

Abstract

BACKGROUND: Stress-related mental health problems negatively impact quality of life and productivity. Worldwide, treatment is often sought in primary care. Our objective was to determine whether a general practitioner-based minimal intervention for workers with stress-related sick leave (MISS) was cost-effective compared to usual care (UC).
METHODS: We conducted an economic evaluation from a societal perspective. Quality-adjusted life years (QALYs) and resource use were measured by the EuroQol and cost diaries, respectively. Uncertainty was estimated by 95% confidence intervals, cost-effectiveness planes and acceptability curves. Sensitivity analyses and ancillary analyses based on preplanned subgroups were performed.
RESULTS: No statistically significant differences in costs or QALYs were observed. The mean incremental cost per QALY was -euro 7356 and located in the southeast quadrant of the cost-effectiveness plane, whereby the intervention was slightly more effective and less costly. For willingness-to-pay (lambda) thresholds from euro 0 to euro 100,000, the probability of MISS being cost-effective was 0.58-0.90. For the preplanned subgroup of patients diagnosed with stress-related mental disorders, the incremental ratio was -euro 28,278, again in the southeast quadrant. Corresponding probabilities were 0.92 or greater. LIMITATIONS: Non-significant findings may be related to poor implementation of the MISS intervention and low power. Also, work-presenteeism and unpaid labor were not measured.
CONCLUSIONS: The minimal intervention was not cost-effective compared to usual care for a heterogeneous patient population. Therefore, we do not recommend widespread implementation. However, the intervention may be cost-effective for the subgroup stress-related mental disorders. This finding should be confirmed before implementation for this subgroup is considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19439362     DOI: 10.1016/j.jad.2009.04.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Design of a trial-based economic evaluation on the cost-effectiveness of employability interventions among work disabled employees or employees at risk of work disability: the CASE-study.

Authors:  Cindy Y G Noben; Frans J N Nijhuis; Angelique E de Rijk; Silvia M A A Evers
Journal:  BMC Public Health       Date:  2012-01-18       Impact factor: 3.295

2.  Economic evaluation of a problem solving intervention to prevent recurrent sickness absence in workers with common mental disorders.

Authors:  Iris Arends; Ute Bültmann; Willem van Rhenen; Henk Groen; Jac J L van der Klink
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

3.  Economic Evaluation of an Internet-Based Stress Management Intervention Alongside a Randomized Controlled Trial.

Authors:  Claudia Buntrock; Fanny Kählke; Filip Smit; Matthias Berking; Dirk Lehr; Elena Heber; Burkhardt Funk; Heleen Riper; David Daniel Ebert
Journal:  JMIR Ment Health       Date:  2019-05-15

4.  The Cost-Effectiveness Analysis of the Productivity Measurement and Enhancement System Intervention to Reduce Employee Work-Related Stress and Enhance Work Performance.

Authors:  Irene Jensen; Zana Arapovic-Johansson; Emmanuel Aboagye
Journal:  Int J Environ Res Public Health       Date:  2022-02-19       Impact factor: 3.390

5.  Economic evaluation of return-to-work interventions for mental disorder-related sickness absence: two years follow-up of a randomized clinical trial.

Authors:  Anna Finnes; Jeffrey S Hoch; Pia Enebrink; JoAnne Dahl; Ata Ghaderi; Anna Nager; Inna Feldman
Journal:  Scand J Work Environ Health       Date:  2022-01-30       Impact factor: 5.492

6.  Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.

Authors:  Marieke F van Wier; Jeroen Lakerveld; Sandra D M Bot; Mai J M Chinapaw; Giel Nijpels; Maurits W van Tulder
Journal:  BMC Fam Pract       Date:  2013-04-04       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.